CD8A and endometrial cancer: Compared to microsatellite-stable endometrial cancers, MSI-high/dMMR endometrial cancers exhibit a higher neoantigen burden and contain greater numbers of CD3-positive, CD8-positive, PD-1-expressing tumor-infiltrating lymphocytes, and PD-L1-expressing immune cells within and around the tumor [14].